Clinical trialNCT01096043CompletedPhase 2Interventional

A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure

SponsorBristol-Myers SquibbEnrollment69Heart Failure

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Study CXL-1020-02 employs is designed to further define suitable clinical dosages for CXL-1020 which will be utilized in a later Phase IIb study. The study is conducted in 3 different stages called 'strata" and evaluates the potential utility of this drug for the treatment of patents who are hospitalized with heart failure.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Wilson Colucci, M.D.
Boston University
Study ChairKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Florida
Gainesville, Florida, United States
University of Florida
Jacksonville, Florida, United States
Florida Hospital Transplant Center
Orlando, Florida, United States
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
Dmc Cardiovascular Institute
Detroit, Michigan, United States
Henry Ford Health System
Detroit, Michigan, United States
University of Medicine & Dentistry of New Jersey - New Jersey Medical School
South Orange, New Jersey, United States
Montefiore Medical Center
The Bronx, New York, United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
University of Cincinnati
Cincinnati, Ohio, United States
University Hospitals Case Medical Center
Cleveland, Ohio, United States
Davis Heart & Lung Research Institute
Columbus, Ohio, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Stern Cardiovascular Center Pa
Germantown, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboStrata 1 CXL-1020Strata 2 CXL-1020Strata 3 CXL-1020

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2010
Primary completion: 29 Feb 2012
Completion: 29 Feb 2012
Last update posted: 15 Nov 2016
Registered enrollment: 69
Registry id: NCT01096043

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.